JPMorgan Chase & Co’s MindMed MNMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $315K | Buy |
48,487
+2,342
| +5% | +$15.2K | ﹤0.01% | 4258 |
|
2025
Q1 | $270K | Sell |
46,145
-2,013
| -4% | -$11.8K | ﹤0.01% | 4318 |
|
2024
Q4 | $335K | Buy |
48,158
+11,163
| +30% | +$77.7K | ﹤0.01% | 4329 |
|
2024
Q3 | $211K | Buy |
36,995
+2,797
| +8% | +$15.9K | ﹤0.01% | 4441 |
|
2024
Q2 | $247K | Buy |
34,198
+30,682
| +873% | +$221K | ﹤0.01% | 4178 |
|
2024
Q1 | $33.1K | Hold |
3,516
| – | – | ﹤0.01% | 5099 |
|
2023
Q4 | $12.9K | Hold |
3,516
| – | – | ﹤0.01% | 5332 |
|
2023
Q3 | $11K | Buy |
3,516
+3,500
| +21,875% | +$11K | ﹤0.01% | 5291 |
|
2023
Q2 | $75 | Hold |
16
| – | – | ﹤0.01% | 5807 |
|
2023
Q1 | $0 | Hold |
16
| – | – | ﹤0.01% | 6009 |
|
2022
Q4 | $0 | Hold |
16
| – | – | ﹤0.01% | 5793 |
|
2022
Q3 | $0 | Sell |
16
-1
| -6% | – | ﹤0.01% | 5705 |
|
2022
Q2 | $1K | Sell |
17
-10,070
| -100% | -$592K | ﹤0.01% | 5495 |
|
2022
Q1 | $168K | Buy |
10,087
+1,111
| +12% | +$18.5K | ﹤0.01% | 4531 |
|
2021
Q4 | $631K | Buy |
8,976
+397
| +5% | +$27.9K | ﹤0.01% | 3938 |
|
2021
Q3 | $603K | Sell |
8,579
-12,306
| -59% | -$865K | ﹤0.01% | 3871 |
|
2021
Q2 | $1.47M | Buy |
+20,885
| New | +$1.47M | ﹤0.01% | 3409 |
|